BlackRock Fund Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

BlackRock Fund Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$103K	Buy	25,426 +3,863	+18%	+$18K	﹤0.01%	3605
2016 Q3	$157K	Buy	21,563 +12,728	+144%	+$86K	﹤0.01%	3527
2016 Q2	$45K	Buy	8,835 +5,527	+167%	+$102K	﹤0.01%	3848
2016 Q1	$71K	Sell	3,308 -155	-4%	-$3.28K	﹤0.01%	3740
2015 Q4	$106K	Buy	3,463 +408	+13%	+$12K	﹤0.01%	3716
2015 Q3	$102K	Buy	+3,055	New	+$172K	﹤0.01%	3696

Other funds holding MRNS

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock Fund Advisors's MRNS Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Marinus Pharmaceuticals, Inc (MRNS) stake by 18% in Q4 2016, buying an estimated $18K and bringing the position to 25,426 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #3605.

BlackRock Fund Advisors first reported a position in MRNS in Q3 2015 and has held it in 6 quarters since. The position peaked at $157K in Q3 2016. 23 funds tracked by Wall St. Rank hold MRNS as of Q4 2016.

BlackRock Fund Advisors held 25,426 shares of Marinus Pharmaceuticals, Inc worth $103K as of Q4 2016.
BlackRock Fund Advisors bought 3,863 Marinus Pharmaceuticals, Inc shares in Q4 2016, an estimated $18K.
Marinus Pharmaceuticals, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3605 holding.
BlackRock Fund Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q3 2015 and has held it in 6 quarters since.
BlackRock Fund Advisors's Marinus Pharmaceuticals, Inc position peaked at $157K in Q3 2016.
23 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.